45754e78d82e2680…

{
  "id": "NCT00018382",
  "type": "Study",
  "data": {
    "briefSummary": "This study examines the use of insulin-sensitizing compounds, as therapeutic agents for cognitive impairment in Alzheimer's disease.",
    "completionDate": "2003-03",
    "conditions": [
      "Alzheimer Disease"
    ],
    "enrollmentCount": null,
    "enrollmentType": null,
    "nctId": "NCT00018382",
    "phase": "PHASE2",
    "sponsorId": "us-department-of-veterans-affairs",
    "startDate": "1999-10",
    "status": "COMPLETED",
    "studyType": "INTERVENTIONAL",
    "title": "Insulin, Neurogenetics and Memory in Alzheimer's Disease: A Novel Therapeutic Approach",
    "url": "https://clinicaltrials.gov/study/NCT00018382"
  }
}